29 Sep 2023

Healthcare Marketing Daily is BulletinHealthcare’s complimentary email news briefing curated for healthcare marketers in search of the latest developments impacting their profession. We apply our expertise from producing briefings for 30+ leading medical associations to bring our readers the most important news affecting healthcare marketers. Our aim is to help our readers start the day with actionable insights from our seasoned analysts and conserve their most precious resource: their time.

We close each month with a Monthly Wrap Up edition, which features a collection of the month’s most engaging stories.

Without further ado, below are the top headlines of September 2023!

Top Stories of September 2023

1. Johnson & Johnson Unites Janssen, Medtech Segments Under One Brand, Reveals New Logo.
Johnson & Johnson announced a major corporate rebranding effort that involved merging its pharmaceutical and medical technology divisions to strengthen their connection to the Johnson & Johnson brand, with the Janssen brand set to evolve into Johnson & Johnson Innovate Medicine, while the medical technology segment will retain the J&J MedTech name.

2. Eli Lilly Representatives Plan To Attend Digital Pharma East Conference.
At the Digital Pharma East Conference, representatives from Lilly participated in a panel discussion titled “Pharma’s Digital Future: How Technology and Innovation Were Poised to Disrupt the Industry.”
Medical Marketing & Media

3. AstraZeneca Runs Digital Campaign For Cardiovascular, Renal, Metabolic Portfolio.
AstraZeneca launched a digital campaign and a two-minute short film to highlight its cardiovascular, renal, and metabolic (CVRM) portfolio and outlined its ambitions in addressing these interconnected diseases.
Endpoints News

4. Incyte Launches Opzelura Eczema Campaign With ‘Reimagine Relief’ Theme.
Incyte’s campaign for Opzelura (ruxolitinib) encouraged itchy patients to “Reimagine Relief,” offering a topical, steroid-free alternative in the competitive eczema treatment market, specifically targeting individuals averse to needles and oral systemic biologics.
Endpoints News

5. Doximity Says Telemedicine Shift Opens New Avenues For Pharma Marketing.
The 2023 Telemedicine Report by Doximity showed widespread adoption of telehealth by patients and physicians, with ZS Associates’ AccessMonitor report revealing that over half of U.S. physicians had limited access to pharmaceutical representatives, making telehealth a vital platform for “digital point of care” advertising.
Medical Marketing & Media

If you’re a healthcare marketing insider — or want to become one — sign up for Healthcare Marketing Daily to receive the latest news and industry insights.